Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

In this Oct. 7, 2019, file photo, a pharmacist displays the HIV prevention drugs Descovy, left and Truvada, right, at a pharmacy in Sacramento, Calif. A proposed federal policy aims to protect older ...

The overwhelming majority of people who face a high risk from the virus are not receiving key medications to prevent infection due to deep racial disparities in access to treatment, according to the ...

Thousands of low-income Americans with HIV are losing access to vital medications, as states grapple with a lack of federal ...

As part of its effort to prevent and treat HIV, Philadelphia has launched a new online tool to connect people with a range of sexual health and community resources. "When we were doing a survey of the ...

A couple of years ago, Matthew Hurley got the kind of text people fear. It said: "When was the last time you were STD tested?" Someone Hurley had recently had unprotected sex with had just tested ...

Billing mistakes. Stigma. Doctors who aren’t keeping up with the latest research. Those are just some of the hurdles that keep HIV prevention medication out of reach for many Americans. The Centers ...

In his 2019 State of the Union address, President Donald Trump pledged to boost HIV spending, with the lofty goal of bringing the nation’s epidemic to heel by 2030. Last year, this federal initiative, ...